Retour
Fourchette du Jour
19,23 €
20,08 €
Fourchette 52 Semaines
17,03 €
31,26 €
Volume
394 739
Moyenne 50J / 200J
24,98 €
/
25,55 €
Clôture Précédente
19,50 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,0 | 0,4 |
| P/B | 1,1 | 2,9 |
| ROE % | 12,9 | 3,8 |
| Net Margin % | 13,6 | 3,9 |
| Rev Growth 5Y % | 13,2 | 10,0 |
| D/E | 0,8 | 0,2 |
Points Clés
Revenue grew 13,24% annually over 5 years — strong growth
Earnings declined -38,51% over the past year
ROE of 12,90% — decent returns on equity
Generating 121,23M in free cash flow
P/E of 9,01 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,89%
Croissance
Revenue Growth (5Y)
13,24%
Revenue (1Y)-1,65%
Earnings (1Y)-38,51%
FCF Growth (3Y)-8,67%
Qualité
Return on Equity
12,90%
ROIC7,29%
Net Margin13,63%
Op. Margin19,50%
Sécurité
Debt / Equity
0,83
Current Ratio4,02
Interest Coverage5,51
Valorisation
P/E Ratio
9,01
P/B Ratio1,12
EV/EBITDA9,75
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,65% | Revenue Growth (3Y) | 5,70% |
| Earnings Growth (1Y) | -38,51% | Earnings Growth (3Y) | -15,55% |
| Revenue Growth (5Y) | 13,24% | Earnings Growth (5Y) | 12,10% |
| Profitability | |||
| Revenue (TTM) | 719,89M | Net Income (TTM) | 98,09M |
| ROE | 12,90% | ROA | 6,02% |
| Gross Margin | 49,46% | Operating Margin | 19,50% |
| Net Margin | 13,63% | Free Cash Flow (TTM) | 121,23M |
| ROIC | 7,29% | FCF Growth (3Y) | -8,67% |
| Safety | |||
| Debt / Equity | 0,83 | Current Ratio | 4,02 |
| Interest Coverage | 5,51 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 9,01 | P/B Ratio | 1,12 |
| P/S Ratio | 1,23 | PEG Ratio | -0,35 |
| EV/EBITDA | 9,75 | Dividend Yield | 0,00% |
| Market Cap | 883,66M | Enterprise Value | 1,37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 719,89M | 731,97M | 644,40M | 498,99M | 437,77M |
| Net Income | 98,09M | 159,52M | 137,55M | 91,39M | 62,12M |
| EPS (Diluted) | 2,03 | 3,06 | 2,60 | 1,74 | 1,25 |
| Gross Profit | 356,06M | 373,86M | 351,12M | 248,86M | 199,74M |
| Operating Income | 140,40M | 205,42M | 196,99M | 107,50M | 69,89M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,63B | 1,58B | 1,51B | 741,99M | 671,53M |
| Total Liabilities | 840,49M | 845,17M | 873,49M | 213,33M | 226,01M |
| Shareholders' Equity | 788,81M | 732,30M | 639,42M | 528,66M | 445,52M |
| Total Debt | 656,00M | 650,55M | 623,64M | 102,58M | 104,66M |
| Cash & Equivalents | 170,18M | 151,61M | 144,30M | 156,10M | 126,35M |
| Current Assets | 636,02M | 534,07M | 489,60M | 378,32M | 318,12M |
| Current Liabilities | 158,16M | 173,76M | 225,41M | 94,86M | 103,81M |